You are here

ImmPORT Therapeutics Inc dba Antigen Discovery Inc

Company Information
Address
1 Technology Drive E309
Irvine , CA 92618
United States


http://www.antigendiscovery.com

Information

UEI: ZJAMPJY7M149

# of Employees: 15


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus

    Amount: $243,000.00

    ABSTRACT: A novel human coronavirus, which causes severe acute respiratory disease, now known as SARSCoV-2 emerged in December 2019. Infection with SARS-CoV-2 spread rapidly worldwide and on 11 March ...

    SBIRPhase I2021Department of Health and Human Services Centers for Disease Control and Prevention
  2. Identification of bactericidal antibody specificities for the development of novel broad-coverage vaccine candidates against Neisseria meningitidis

    Amount: $596,034.00

    ABSTRACT Neisseria meningitidis (Nm) is a Gram-negative bacterium that commonly colonizes the human pharyngeal mucosa, but can also cause invasive meningococcal disease (IMD), a devastating disease th ...

    SBIRPhase I2021Department of Health and Human Services National Institutes of Health
  3. Discovery of Treponema pallidum antigens for development of a sensitive and specific diagnostic test for syphilis

    Amount: $600,000.00

    In spite of being perceived as a disease of the past, syphilis remains a serious global health problem, affecting millions worldwide in both developing and developed countries. In underprivileged sett ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  4. Scanning the Cryptosporidium proteome for vaccine antigens

    Amount: $599,999.00

    Cryptosporidiosis is a top ten cause of infant diarrhea in low and middle-income countries (LMICs), as well as malnutrition and impaired neurocognitive development, leading to substantial yearly morbi ...

    SBIRPhase I2020Department of Health and Human Services National Institutes of Health
  5. Identification of Brucella canis seroreactive antigens using a pan Brucella proteome microarray

    Amount: $150,000.00

    Brucellosis is a worldwide re emerging bacterial zoonosis that can affect a range of different mammals including cattlesheepgoatsswinedogsand importantly humansEvery yearmore thanpeople worldwide are ...

    SBIRPhase I2018Department of Health and Human Services Centers for Disease Control and Prevention
  6. Pan-HIV Incidence Assay Development

    Amount: $225,707.00

    PanHIV Incidence Assay DevelopmentAbstractHIVcontinues to cause the largest number of yearly deaths from a single infectious agent in the world todayDespiteconsiderableadvancesintreatmentofHIVinfectio ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  7. Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay

    Amount: $595,243.00

    DiscoveryofYellowFever VirusSpecificEpitopesforDevelopmentofanAccurateSerodiagnostic AssayAbstractAntibodies to many pathogenic viruses can be detected in bloodserum and or salivaAmong theseare many a ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  8. Protective biomarkers for the development of novel serotype-independent protein-based vaccine candidates against pneumococcus

    Amount: $224,852.00

    Streptococcus pneumoniaethe pneumococcusis the most common cause of severe pneumoniaanddespite the existence of licensed vaccinesannually kills half of a million children under five years old worldwid ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  9. Specific Detection of Antibodies to Emerging and Established Arboviruses Including Zika Virus

    Amount: $224,958.00

    Abstract Zika virus ZIKV infection is currently an epidemic in the western hemisphere It is a WHO declared Public Health Emergency of International Concern since February due to the as ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  10. A NOVEL IMMUNO-PROTEOMIC APPROACH TO A GENITAL HERPES VACCINE

    Amount: $224,911.00

    DESCRIPTION provided by applicant Over a half billion individuals worldwide are infected with herpes simplex virus type and or type HSV andamp HSV which cause genital herpes Most HSV ...

    SBIRPhase I2016Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government